Share

Congratulations to Dr. Hans Wildiers, winner of the B.J. Kennedy Geriatric Oncology Award

Congratulations to our longstanding member Dr. Hans Wildiers for receiving the B.J. Kennedy Geriatric Oncology Award at the 2023 ASCO Annual Meeting.

Created in 2007 in honour of B.J. Kennedy, MD, this award recognises an ASCO member who has made outstanding contributions to the research, diagnosis, and treatment of cancer in the elderly, and in bringing an understanding of geriatric oncology to fellows and junior faculty.

During the Award Lecture (session available on-demand for participants), Dr. Wildiers presented a session titled “Looking Back and Moving Forward” where he focused on the achievements in the field of geriatric oncology and the work that is still needed to improve the care of older patients with cancer.

During his presentation, he thanked organisations like EORTC, which have strongly supported geriatric oncology research in the last years.

“It is my great honour to receive this year’s the B.J. Kennedy Geriatric Oncology Award. […] Within the EORTC, we had a lot of discussions on the optimal trial design for older patients with cancer.”

– Dr. Hans Wildiers

Dr. Wildiers is a medical oncologist dedicated to breast cancer research. He has served as a staff member in the Department of Medical Oncology at the University Hospital Leuven, Belgium, since 2004. Since 2015, he has been the coordinator of the Leuven Multidisciplinary Breast Center. He has also been the coordinator of several academic studies in the field of breast cancer and geriatric oncology and is the author of more than 350 peer-reviewed papers. He has been active on the Board of the International Society of Geriatric Oncology for many years and served as the organisation’s president from 2018 to 2020. From 2009 to 2015, he chaired the Cancer in the Elderly Task Force of the European Organisation for Research and Treatment of Cancer (EORTC).

More information here.

Back to news list

Related News

  • EORTC calls for a balanced and feasible European Health Data Space (EHDS)

  • Professor Benjamin Besse becomes President of EORTC

  • CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer

  • EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials

  • New study confirms a key quality of life tool can be used with adolescents with cancer

  • “Changing practice, improving lives”: EORTC publishes its Annual Report 2025

  • This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research

  • Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer

  • Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma

  • EORTC’s presence at ESTRO 2026